CYP3A4, cytochrome P450 family 3 subfamily A member 4, 1576
N. diseases: 291; N. variants: 17
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.807 | 0.360 | 7 | 99784473 | upstream gene variant | C/T | snv | 0.78 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.807 | 0.360 | 7 | 99784473 | upstream gene variant | C/T | snv | 0.78 |
|
Female Urogenital Diseases and Pregnancy Complications; Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2010 | 2010 | |||||||
|
0.807 | 0.360 | 7 | 99784473 | upstream gene variant | C/T | snv | 0.78 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.807 | 0.360 | 7 | 99784473 | upstream gene variant | C/T | snv | 0.78 |
|
Female Urogenital Diseases and Pregnancy Complications; Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2010 | 2010 | |||||||
|
0.807 | 0.360 | 7 | 99784473 | upstream gene variant | C/T | snv | 0.78 |
|
Immune System Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.807 | 0.360 | 7 | 99784473 | upstream gene variant | C/T | snv | 0.78 |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.807 | 0.360 | 7 | 99784473 | upstream gene variant | C/T | snv | 0.78 |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.807 | 0.360 | 7 | 99784473 | upstream gene variant | C/T | snv | 0.78 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.807 | 0.360 | 7 | 99784473 | upstream gene variant | C/T | snv | 0.78 |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 7 | 99768693 | intron variant | G/A | snv | 3.2E-02 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.120 | 7 | 99762071 | stop gained | C/T | snv | 1.2E-05 | 7.0E-06 |
|
0.010 | 1.000 | 1 | 2004 | 2004 | |||||||
|
0.882 | 0.120 | 7 | 99762071 | stop gained | C/T | snv | 1.2E-05 | 7.0E-06 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||
|
0.882 | 0.120 | 7 | 99762071 | stop gained | C/T | snv | 1.2E-05 | 7.0E-06 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||
|
1.000 | 0.080 | 7 | 99767248 | synonymous variant | T/C | snv | 1.8E-05 | 3.5E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
7 | 99758352 | intron variant | T/C | snv | 0.31 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.827 | 0.200 | 7 | 99767460 | intron variant | G/A | snv | 0.30 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.827 | 0.200 | 7 | 99767460 | intron variant | G/A | snv | 0.30 |
|
Pathological Conditions, Signs and Symptoms; Digestive System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.827 | 0.200 | 7 | 99767460 | intron variant | G/A | snv | 0.30 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.827 | 0.200 | 7 | 99767460 | intron variant | G/A | snv | 0.30 |
|
Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.827 | 0.200 | 7 | 99767460 | intron variant | G/A | snv | 0.30 |
|
0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.827 | 0.200 | 7 | 99767460 | intron variant | G/A | snv | 0.30 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.827 | 0.200 | 7 | 99767460 | intron variant | G/A | snv | 0.30 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
7 | 99763247 | intron variant | G/A | snv | 5.1E-02 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||||
|
7 | 99763247 | intron variant | G/A | snv | 5.1E-02 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.925 | 0.080 | 7 | 99760901 | missense variant | A/G | snv | 5.2E-03 | 5.1E-03 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 |